Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes

JM Long, DW Coble, C Xiong, SE Schindler, RJ Perrin… - Brain, 2022 - academic.oup.com
Alzheimer's disease biomarkers are widely accepted as surrogate markers of underlying
neuropathological changes. However, few studies have evaluated whether preclinical …
被引用次数：25 相关文章

Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes

JM Long, DW Coble, C Xiong, SE Schindler, RJ Perrin… - Brain, 2022 - academic.oup.com
Alzheimer's disease biomarkers are widely accepted as surrogate markers of underlying
neuropathological changes. However, few studies have evaluated whether preclinical …

Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes

JM Long, DW Coble, C Xiong… - Brain: a journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease biomarkers are widely accepted as surrogate markers of underlying
neuropathological changes. However, few studies have evaluated whether preclinical …

Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes

JM Long, DW Coble, C Xiong, SE Schindler, RJ Perrin… - Brain, 2022 - profiles.wustl.edu
Alzheimer's disease biomarkers are widely accepted as surrogate markers of underlying
neuropathological changes. However, few studies have evaluated whether preclinical …

Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.

JM Long, DW Coble, C Xiong, SE Schindler… - Brain: a Journal of …, 2022 - europepmc.org
Alzheimer's disease biomarkers are widely accepted as surrogate markers of underlying
neuropathological changes. However, few studies have evaluated whether preclinical …
[HTML] nih.gov

[HTML][HTML] Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes

JM Long, DW Coble, C Xiong, SE Schindler, RJ Perrin… - Brain, 2022 - ncbi.nlm.nih.gov
Alzheimer's disease biomarkers are widely accepted as surrogate markers of underlying
neuropathological changes. However, few studies have evaluated whether preclinical …